Plain English
Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.
Market Impact Map
Action Timeline
2025-03-14
Referred to the House Committee on Energy and Commerce.
2025-03-14
Introduced in House
2025-03-14
Introduced in House
Full Bill Text
119 HR 2168 IH: Baby Observation Act U.S. House of Representatives 2025-03-14 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 1st Session H. R. 2168 IN THE HOUSE OF REPRESENTATIVES March 14, 2025 Mr. Yakym introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To direct the Secretary of Health and Human Services to conduct a study and submit to Congress a report on the use of home cardiorespiratory monitors for infants, and for other purposes. 1. Short title This Act may be cited as the Baby Observation Act or the BO’s Act . 2. Study and report on home cardiorespiratory monitors for infants (a) Study The Secretary of Health and Human Services (in this section referred to as the Secretary ), pursuant to section 1121(a) of the Public Health Service Act ( 42 U.S.C. 300c–11(a) ), shall conduct a study on the use of home cardiorespiratory monitors for infants in relation to the prevention of sudden unexpected infant death (as defined in section 1121(e) of such Act ( 42 U.S.C. 300c–11(e) )). (b) Report Not later than 1 year after the date of enactment of this Act, the Secretary shall submit to Congress a report describing the results of the study under subsection (a). Such report shall include the following: (1) Evidence on the effectiveness, performance, and accuracy of home cardiorespiratory monitors that track the heart rate, blood oxygen levels, and other vital signs of an infant. (2) New models of care to improve the home sleeping environment of an infant, including the use of cardiorespiratory monitors. (3) Health care plan criteria for medically appropriate coverage for a home cardiorespiratory monitor. (4) Recommendations on whether home cardiorespiratory monitors have shown product efficacy supporting coverage under public or private health insurance plans.
Loading intelligence layer…